SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-035726
Filing Date
2024-03-18
Accepted
2024-03-18 20:01:28
Documents
1
Period of Report
2024-03-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm249071-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm249071-2_4seq1.xml 4 6337
  Complete submission text file 0001104659-24-035726.txt   7978
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 601 108TH AVENUE NE, SUITE 1200 BELLEVUE WA 98004
Business Address
Haimovitz Jules (Reporting) CIK: 0001340855 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 24760710